Business
Schrödinger Partners with Lilly to Make TuneLab Platform Available in LiveDesign
NEW YORK, January 09, 2026--Schrödinger, Inc. (Nasdaq: SDGR) today announced a collaboration with Lilly TuneLab™, a platform launched by Eli Lilly and Company (Lilly) designed to accelerate drug discovery and development by providing access to advanced artificial intelligence (AI) capabilities. TuneLab will be made available in LiveDesign, Schrödinger’s widely used enterprise informatics platform, as a priority interface for participating biotech companies to access TuneLab workflows.
About this update from Eli Lilly And Company
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":1024,"height":512,"url":"https://media.zenfs.com/en/business-wire.com/265dd09e6c994bd31c4ce58ff55d9e1a"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/Ac7YZaIakTR9ZpV7xrGPdA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTQ4MDtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/265dd09e6c994bd31c4ce58ff55d9e1a","width":960,"height":480},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/HkoCIskRPA0Okdzgtj2b4g--/YXBwaWQ9aGlnaGxhbmRlcjt3PTIwNDg7aD0xMDI0O2NmPXdlYnA-/https://media.zenfs.com/en/business-wire.com/265dd09e6c994bd31c4ce58ff55d9e1a","width":1024,"height":512}},"lazy":false},{"type":"text","content":"NEW YORK, January 09, 2026--(BUSINESS WIRE)--Schrödinger, Inc. (Nasdaq: SDGR) today announced a collaboration with Lilly TuneLab™, a platform launched by Eli Lilly and Company (Lilly) designed to accelerate drug discovery and development by providing access to advanced artificial intelligence (AI) capabilities. TuneLab will be made available in LiveDesign, Schrödinger’s widely used enterprise informatics platform, as a priority interface for participating biotech companies to access TuneLab workflows.","length":506,"tagName":"p"},{"type":"text","content":""As a leader in computational drug discovery, Schrödinger is pleased to partner with Lilly TuneLab," stated Pat Lorton, chief technology officer and chief operating officer, software at Schrödinger. "We are pleased that LiveDesign will be a priority platform partner for TuneLab workflows, reflecting the demand for a unified enterprise informatics solution that democratizes access to AI models, physics-based calculations, and experimental data across discovery teams."","length":491,"tagName":"p"},{"type":"text","content":""Schrödinger has a long history of working with partners to accelerate drug discovery. We are pleased to be partnering with Lilly to expand the use of digital drug design methods, and ultimately drive greater impact for patients," said Karen Akinsanya, president of R&D, therapeutics, and chief strategy officer, partnerships. "Schrödinger has a track record of successfully leveraging LiveDesign’s array of enterprise features, including physics-based and AI/ML methods, to advance our proprietary...